More
    Guided Solutions - Connecting Talent With Innovation/div>

    Study backs Median Technologies’ AI lung cancer screening software

    Median Technologies, manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a...

    New study demonstrates benefit of Neo Medical’s spine surgery tech

    A new study has demonstrated the value of Neo Medical’s Force Control technology and pedicle screws in thoracolumbar fusion spine surgery. Published in the April...

    JenaValve data backs TAVR system for treating aortic regurgitation

    JenaValve announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system. The ALIGN-AR pivotal trial evaluated Trilogy in high-risk...

    AtaCor Medical enrolls first patient in ASCEND-EV trial

    AtaCor Medical launched its clinical study evaluating its extravascular implantable cardioverter defibrillator (EV-ICD) lead system. The San Clemente, California–based company enrolled its first patient...

    RevBio initiates pivotal Europe trial for its dental implant stabilization product

    RevBio, Inc., announced it received regulatory and ethics committee approvals in multiple European countries to conduct its pivotal clinical trial for its dental implant...

    Cognixion launches trial of BCI device paired with AI application for people with ALS

    Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI device. The clinical trial evaluates the Axon-R device paired...

    Second Heart Assist’s Whisper device caused less hemolysis compared to Abiomed Impella CP

    Second Heart Assist announced data from a study highlighting the performance of its Whisper device against a competitive heart pump. The study showed that...

    Lungpacer wins FDA IDE for AeroNova system

    Lungpacer Medical received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system. The STARI (stimulation to activate respiration) trial evaluates the...

    Neuspera has positive data for percutaneous sacral neuromod system

    Neuspera Medical announced six-month pivotal clinical trial data highlighting the efficacy of its battery-free percutaneous sacral neuromodulation (pSNM) system. Findings showed comparable efficacy with the...

    Latest articles